Cargando…
A genetic variant in GLP1R is associated with response to DPP-4 inhibitors in patients with type 2 diabetes
Incretin hormone-based therapy in type 2 diabetes has been widely used, and dipepdityl peptidase-4 (DPP-4) inhibitors, which prevent incretin degradation, have become popular oral hypoglycemic agents. The efficacy of DPP-4 inhibitors varies from individuals, and factors determining responses to DPP-...
Autores principales: | Han, Eugene, Park, Hye Sun, Kwon, Obin, Choe, Eun Yeong, Wang, Hye Jin, Lee, Yong-ho, Lee, Sang-Hak, Kim, Chul Hoon, Kim, Lee-Kyung, Kwak, Soo Heon, Park, Kyong Soo, Kim, Chul Sik, Kang, Eun Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591096/ https://www.ncbi.nlm.nih.gov/pubmed/27858848 http://dx.doi.org/10.1097/MD.0000000000005155 |
Ejemplares similares
-
RAS Mutations in AUS/FLUS Cytology: Does it Have an Additional Role in BRAF(V600E) Mutation-Negative Nodules?
por: Yoon, Jung Hyun, et al.
Publicado: (2015) -
The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes
por: Choe, Eun Yeong, et al.
Publicado: (2014) -
Kallmann syndrome with a Tyr113His PROKR2 mutation
por: Ha, Jeong-Ha, et al.
Publicado: (2017) -
Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma
por: Lee, Hye Won, et al.
Publicado: (2017) -
Long interspersed nuclear element-1 hypomethylation is associated with poor outcomes via the activation of ST18 in human hepatocellular carcinoma
por: Lee, Yu Rim, et al.
Publicado: (2021)